Aristotle Atlantic Partners, LLC Bio Techne Corp Transaction History

Aristotle Atlantic Partners, LLC

$3.16 Billion
Q4 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 754,362 shares of TECH stock, worth $49.5 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

754,362

Previous 785,504 3.96%

Holding current value

$49.5 Million

Previous $62.8 Million 13.43%

% of portfolio

1.72%

Previous 1.96%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$66.37 - $78.17 $2.07 Million - $2.43 Million	-31,142 Reduced 3.96%	754,362 $54.3 Million
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $4.53 Million - $5.26 Million	63,835 Added 8.85%	785,504 $62.8 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $875,270 - $1.19 Million	-14,090 Reduced 1.92%	721,669 $51.7 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $1.56 Million - $1.82 Million	-23,655 Reduced 3.11%	735,759 $51.8 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $5.59 Million - $8.27 Million	105,779 Added 16.18%	759,414 $58.6 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $579,254 - $767,134	-8,579 Reduced 1.3%	653,635 $44.5 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $10.3 Million - $12 Million	139,028 Added 26.57%	662,214 $54.1 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $1,217 - $1,472	-17 Reduced -0.0%	523,186 $38.8 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $31.8 Million - $139 Million	394,118 Added 305.32%	523,203 $43.4 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $10.1 Million - $14 Million	35,818 Added 38.4%	129,085 $36.7 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $1.21 Million - $1.69 Million	-3,758 Reduced 3.87%	93,267 $32.3 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $505,297 - $696,564	1,428 Added 1.49%	97,025 $42 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $2.03 Million - $2.33 Million	4,445 Added 4.88%	95,597 $49.5 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $467,113 - $565,824	1,050 Added 1.17%	91,152 $44.2 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $424,148 - $493,034	1,095 Added 1.23%	90,102 $40.6 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $633,644 - $827,754	2,014 Added 2.32%	89,007 $34 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $1.15 Million - $1.5 Million	-4,669 Reduced 5.09%	86,993 $27.6 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $241,044 - $293,712	1,038 Added 1.15%	91,662 $22.7 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $2.89 Million - $4.36 Million	15,600 Added 20.79%	90,624 $23.9 Million
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $1.69 Million - $2.32 Million	-10,487 Reduced 12.26%	75,024 $14.2 Million
Q4 2019 Feb 13, 2020	BUY	$189.68 - $222.09 $9.96 Million - $11.7 Million	52,534 Added 159.3%	85,511 $18.8 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $191,820 - $226,472	1,045 Added 3.27%	32,977 $6.45 Million
Q2 2019 Aug 13, 2019	BUY	$188.72 - $215.43 $268,926 - $306,987	1,425 Added 4.67%	31,932 $6.66 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $180,999 - $266,585	1,330 Added 4.56%	30,507 $6.06 Million
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $1.08 Million - $1.66 Million	8,147 Added 38.74%	29,177 $4.22 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $896,435 - $1.24 Million	-6,080 Reduced 22.43%	21,030 $4.12 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $2.48 Million - $2.83 Million	17,110 Added 171.1%	27,110 $4.01 Million
Q1 2018 Sep 10, 2018	BUY	$131.46 - $151.04 $1.31 Million - $1.51 Million	10,000 New	10,000 $1.51 Million

Others Institutions Holding TECH

# of Institutions

615

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.57B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Bio Techne Corp Transaction History